We use cookies for a better user experience. Read our Privacy Policy
I Agree
Photodynamic Therapy Market
Analysts’ Viewpoint on Photodynamic Therapy Market Scenario
Photodynamic therapy (PDT) is a part of treatment that uses drugs and devices for the treatment of chronic diseases such as cancer and malignant musculoskeletal tumors. Novel light-emitting devices are gaining traction for actinic keratosis treatment. Companies in the photodynamic treatment industry are consolidating their position through inorganic strategies such as label extensions. However, PDT faces common issues in drug-resistant breast cancer treatment, such as blood artery blockage, collapse, and final vascular shutdown. Therefore, companies should intensify their efforts to assess the benefits of photochemical internalization in facilitating the cytosolic transport of macromolecular medications to fight multidrug-resistant breast cancer.
The global photodynamic therapy market is expected to be driven by the increase in incidence of skin diseases & cancer, rise in demand for minimally invasive procedures, and growth in the economic burden of cancer. Approval of novel biologics by regulatory agencies in developed and developing countries has provided patients with additional therapy alternatives. Companies offering photodynamic therapy are working on techniques to increase transdermal ALA delivery. They are creating micro-hole grating with high-power CO2 lasers. The usage of a soluble microneedle patch is another method that allows for continual ALA administration until the material gets entirely dissolved inside the lesion. Rise in awareness about photodynamic therapy benefits; and increase in adoption of face photodynamic therapy, eye photodynamic therapy, and acne photodynamic therapy are driving the global market. Rise in R&D activities in photodynamic therapy analysis is creating lucrative opportunities for market players.
Request a sample to get extensive insights into the Photodynamic Therapy Market
Skin infections are quite frequent, ranking fourth among the most common ailments globally. These are one of the leading causes of non-fatal disability, particularly in developing countries. Hence, there is a need to create a treatment regimen in order to reduce the economic burden of skin disorders in low-resource settings. Acne is one of the most prevalent skin disorders in the U.S., affecting around 50 million individuals each year. Its prevalence is higher in women, affecting more than 15% of the entire adult female population. The prevalence of herpes is higher in poor countries than in wealthy countries. Rise in genital herpes cases is part of a rapidly shifting picture of sexually transmitted disease epidemiology in emerging economies. Increase in prevalence of skin disorders and surge in economic burden of these illnesses have created a need for cost-effective treatment options. This is likely to augment the global photodynamic treatment market.
In terms of product type, the global photodynamic therapy market has been bifurcated into photosensitizer drugs and devices. The photosensitizer drugs segment has been classified into porphyrin derivative (PD), aminolevulinic acid (ALA), and chlorines. The devices segment has been split into disposable fiber optic light delivery devices (DFOLDD) and diode lasers. The photosensitizer drugs segment held major share of the global market in 2021. The segment is projected to grow at a high CAGR during the forecast period owing to benefits such as high speed, low cost, and synthetic construction. Moreover, the chemical & physical stability of photosensitizer drugs and their photo cytotoxicity are anticipated to propel the segment.
Request a custom report on Photodynamic Therapy Market
Based on application, the global photodynamic therapy market has been categorized into cancer, actinic keratosis (AK), psoriasis, acne, and others. The cancer segment has been split into basal cell carcinoma, non-small cell lung cancer, head & neck cancer, and others. Cancer is the biggest cause of mortality globally. Tobacco use, pollution, changing lifestyles, and transfer of carcinogens and carcinogenic illnesses such as HPV, H. Pylori, and HCV contribute to the increase in cancer prevalence throughout the world. For instance, according to the National Cancer Institute, about 1,735,350 new cancer cases were likely to be diagnosed in the U.S. in 2018. The global photodynamic therapy market is expected to be driven by the rise in demand for photosensitizer medication and equipment used in the treatment of various forms of cancer.
Surge in demand for PDT due to increase in incidence of various malignancies, rise in number of surgeries, and accessibility of photosensitizer medications & devices are expected to augment the cancer segment during the forecast period. Increase in incidence of various forms of cancer, such as head and neck cancer; and rise in demand for treatment for breast cancer, lung cancer, and basal cell carcinoma treatment are propelling the cancer segment. Leading companies operating in the global photodynamic therapy market have secured drug patents for newly discovered compounds with potential use in photodynamic therapy for cancer treatment. Companies have also increased their focus on developing breast cancer drugs that can be used in photodynamic therapy.
In terms of end-user, the global photodynamic therapy market has been divided into hospitals, cosmetics & dermatology clinics, cancer treatment centers, and others. The hospitals segment is driven by the rise in demand for minimally invasive treatments, increase in awareness about the antitumor effects of PDT, and surge in number of hospitals offering PDT to cancer patients. Hospitals take special precautions to reduce or eliminate exposure to light or laser in order to protect healthy cells. Health care experts offer advice about what to do after treatment and what to avoid so that the therapy is more effective. Useful guidelines related to photodynamic therapy are given to patients in hospitals before and after extraction. This is expected to propel the hospitals segment during the forecast period.
North America is projected to account for the leading share of the global photodynamic therapy market during the forecast period, owing to the presence of key players in the U.S., increase in demand for new biologics for cancer treatment, high rate of adoption of photodynamic therapy, and new product launches by market players. Increase in product approvals by the FDA, surge in usage of photodynamic therapy for the treatment & care of actinic keratosis, and rise in number of cosmetologists providing photodynamic therapy are boosting the photodynamic therapy market in North America.
Europe was the second-largest region of the global photodynamic therapy market in 2021. The market in the region is driven by the increase in research & development activities, rise in number of products receiving CE mark approval, and growth in usage of PDT in cancer treatment. The market in Asia Pacific is driven by the increase in incidence of cancer, psoriasis, and acne; patent awards by regulatory bodies in countries such as China; and geographic expansion by key companies.
The global photodynamic therapy market is consolidated, with the presence of a small number of large-scale players. Key players operating in the global photodynamic therapy market include Galderma Laboratories, L.P., Biofrontera AG, Excel Lasers Limited, LUMIBIRD Group (Quantel Medical), Modulight Corporation, Quest PharmaTech, Inc., Theralase Technologies Inc., and SUS Advancing Technology Co., Ltd. These players are adopting growth strategies such as new product development, product launches, product approval, agreement, partnerships, and mergers.
Each of these players has been profiled in the photodynamic therapy market report based on parameters such as company overview, financial overview, business strategies, product portfolio, business segments, and recent developments.
|
Attribute |
Detail |
|
Market Size Value in 2021 |
US$ 4.2 Bn |
|
Market Forecast Value in 2031 |
More than US$ 15.1 Bn |
|
Growth Rate (CAGR) 2022-2031 |
13.5% |
|
Forecast Period |
2022–2031 |
|
Historical Data Available for |
2017–2021 |
|
Quantitative Units |
US$ Bn for Value |
|
Market Analysis |
It includes segment analysis as well as regional level analysis. Moreover, qualitative analysis includes drivers, restraints, opportunities, key trends, Porter’s Five Forces analysis, value chain analysis, and key trend analysis. |
|
Competition Landscape |
|
|
Format |
Electronic (PDF) + Excel |
|
Market Segmentation |
|
|
Regions Covered |
|
|
Countries Covered |
|
|
Companies Profiled |
|
|
Customization Scope |
Available upon request |
|
Pricing |
Available upon request |
Interested in this report?
Get a FREE Brochure now!
*Get Brochure Report (PDF) sent to your email within minutes
The global photodynamic therapy market was valued at US$ 4.2 Bn in 2021.
The global photodynamic therapy market is projected to reach a value of more than US$ 15.1 Bn by 2031.
The global photodynamic therapy market grew at a CAGR of 13% from 2017 to 2021.
The global photodynamic therapy market is anticipated to grow at a CAGR of 13.5% from 2022 to 2031.
The photosensitizer drugs segment accounted for around 60% share of the global photodynamic therapy market in 2021.
North America is expected to account for major share of the global photodynamic therapy market during the forecast period.
Galderma Laboratories, L.P., Biofrontera AG, Excel Lasers Limited, LUMIBIRD group (Quantel Medical), Modulight Corporation, Quest PharmaTech, Inc., Theralase Technologies, Inc., and SUS Advancing Technology Co., Ltd.
1. Preface
1.1. Market Definition and Scope
1.2. Market Segmentation
1.3. Key Research Objectives
1.4. Research Highlights
2. Assumptions and Research Methodology
3. Executive Summary: Global Photodynamic Therapy Market
4. Market Overview
4.1. Introduction
4.1.1. Segment Definition
4.2. Overview
4.3. Market Dynamics
4.3.1. Drivers
4.3.2. Restraints
4.3.3. Opportunities
4.4. Global Photodynamic Therapy Market Analysis and Forecast, 2017–2031
4.4.1. Market Revenue Projections (US$ Mn)
5. Key Insights
5.1. Key Mergers & Acquisitions
5.2. Technological Advancements
5.3. Covid-19 Impact Analysis
6. Global Photodynamic Therapy Market Analysis and Forecast, by Product Type
6.1. Introduction & Definition
6.2. Key Findings / Developments
6.3. Market Value Forecast, by Product Type, 2017–2031
6.3.1. Photosensitizer Drugs
6.3.1.1. Porphyrin Derivative (PD)
6.3.1.1.1. Hematoporphyrin Derivative (HpD)
6.3.1.1.2. Benzoporphyrin Derivative (BPD)
6.3.1.1.3. Texaphyrins
6.3.1.1.4. Others
6.3.1.2. Aminolevulinic acid (ALA)
6.3.1.3. Chlorines
6.3.1.4. Others
6.3.2. Devices
6.3.2.1. Disposable Fiber Optic Light Delivery Devices (DFOLDD)
6.3.2.2. Diode Laser
6.4. Market Attractiveness Analysis, by Product Type
7. Global Photodynamic Therapy Market Analysis and Forecast, by Application
7.1. Introduction & Definition
7.2. Key Findings / Developments
7.3. Market Value Forecast, by Application, 2017–2031
7.3.1. Cancer
7.3.1.1. Basal Cell Carcinoma
7.3.1.2. Non-Small Cell Lung Cancer
7.3.1.3. Head & Neck Cancer
7.3.1.4. Others
7.3.2. Actinic Keratosis (AK)
7.3.3. Psoriasis
7.3.4. Acne
7.3.5. Others
7.4. Market Attractiveness Analysis, by Application
8. Global Photodynamic Therapy Market Analysis and Forecast, by End-user
8.1. Introduction & Definition
8.2. Key Findings / Developments
8.3. Market Value Forecast, by End-user, 2017–2031
8.3.1. Hospitals
8.3.2. C&DC
8.3.3. CCC
8.3.4. Others
8.4. Market Attractiveness Analysis, by End-user
9. Global Photodynamic Therapy Market Analysis and Forecast, by Region
9.1. Key Findings
9.2. Market Value Forecast, by Region
9.2.1. North America
9.2.2. Europe
9.2.3. Asia Pacific
9.2.4. Latin America
9.2.5. Middle East & Africa
9.3. Market Attractiveness Analysis, by Region
10. North America Photodynamic Therapy Market Analysis and Forecast
10.1. Introduction
10.1.1. Key Findings
10.2. Market Value Forecast, by Product Type, 2017–2031
10.2.1. Photosensitizer Drugs
10.2.1.1. Porphyrin Derivative (PD)
10.2.1.1.1. Hematoporphyrin Derivative (HpD)
10.2.1.1.2. Benzoporphyrin Derivative (BPD)
10.2.1.1.3. Texaphyrins
10.2.1.1.4. Others
10.2.1.2. Aminolevulinic acid (ALA)
10.2.1.3. Chlorines
10.2.1.4. Others
10.2.2. Devices
10.2.2.1. Disposable Fiber Optic Light Delivery Devices (DFOLDD)
10.2.2.2. Diode Laser
10.3. Market Value Forecast, by Application, 2017–2031
10.3.1. Cancer
10.3.1.1. Basal Cell Carcinoma
10.3.1.2. Non-Small Cell Lung Cancer
10.3.1.3. Head & Neck Cancer
10.3.1.4. Others
10.3.2. Actinic Keratosis (AK)
10.3.3. Psoriasis
10.3.4. Acne
10.3.5. Others
10.4. Market Value Forecast, by End-user, 2017–2031
10.4.1. Hospitals
10.4.2. C&DC
10.4.3. CCC
10.4.4. Others
10.5. Market Value Forecast, by Country, 2017–2031
10.5.1. U.S.
10.5.2. Canada
10.6. Market Attractiveness Analysis
10.6.1. By Product Type
10.6.2. By Application
10.6.3. By End-user
10.6.4. By Country
11. Europe Photodynamic Therapy Market Analysis and Forecast
11.1. Introduction
11.1.1. Key Findings
11.2. Market Value Forecast, by Product Type, 2017–2031
11.2.1. Photosensitizer Drugs
11.2.1.1. Porphyrin Derivative (PD)
11.2.1.1.1. Hematoporphyrin Derivative (HpD)
11.2.1.1.2. Benzoporphyrin Derivative (BPD)
11.2.1.1.3. Texaphyrins
11.2.1.1.4. Others
11.2.1.2. Aminolevulinic acid (ALA)
11.2.1.3. Chlorines
11.2.1.4. Others
11.2.2. Devices
11.2.2.1. Disposable Fiber Optic Light Delivery Devices (DFOLDD)
11.2.2.2. Diode Laser
11.3. Market Value Forecast, by Application, 2017–2031
11.3.1. Cancer
11.3.1.1. Basal Cell Carcinoma
11.3.1.2. Non-Small Cell Lung Cancer
11.3.1.3. Head & Neck Cancer
11.3.1.4. Others
11.3.2. Actinic Keratosis (AK)
11.3.3. Psoriasis
11.3.4. Acne
11.3.5. Others
11.4. Market Value Forecast, by End-user, 2017–2031
11.4.1. Hospitals
11.4.2. C&DC
11.4.3. CCC
11.4.4. Others
11.5. Market Value Forecast, by Country/Sub-region, 2017–2031
11.5.1. Germany
11.5.2. U.K.
11.5.3. France
11.5.4. Italy
11.5.5. Spain
11.5.6. Rest of Europe
11.6. Market Attractiveness Analysis
11.6.1. By Product Type
11.6.2. By Application
11.6.3. By End-user
11.6.4. By Country/Sub-region
12. Asia Pacific Photodynamic Therapy Market Analysis and Forecast
12.1. Introduction
12.1.1. Key Findings
12.2. Market Value Forecast, by Product Type, 2017–2031
12.2.1. Photosensitizer Drugs
12.2.1.1. Porphyrin Derivative (PD)
12.2.1.1.1. Hematoporphyrin Derivative (HpD)
12.2.1.1.2. Benzoporphyrin Derivative (BPD)
12.2.1.1.3. Texaphyrins
12.2.1.1.4. Others
12.2.1.2. Aminolevulinic acid (ALA)
12.2.1.3. Chlorines
12.2.1.4. Others
12.2.2. Devices
12.2.2.1. Disposable Fiber Optic Light Delivery Devices (DFOLDD)
12.2.2.2. Diode Laser
12.3. Market Value Forecast, by Application, 2017–2031
12.3.1. Cancer
12.3.1.1. Basal Cell Carcinoma
12.3.1.2. Non-Small Cell Lung Cancer
12.3.1.3. Head & Neck Cancer
12.3.1.4. Others
12.3.2. Actinic Keratosis (AK)
12.3.3. Psoriasis
12.3.4. Acne
12.3.5. Others
12.4. Market Value Forecast, by End-user, 2017–2031
12.4.1. Hospitals
12.4.2. C&DC
12.4.3. CCC
12.4.4. Others
12.5. Market Value Forecast, by Country/Sub-region, 2017–2031
12.5.1. China
12.5.2. India
12.5.3. Japan
12.5.4. Australia & New Zealand
12.5.5. Rest of Asia Pacific
12.6. Market Attractiveness Analysis
12.6.1. By Product Type
12.6.2. By Application
12.6.3. By End-user
12.6.4. By Country/Sub-region
13. Latin America Photodynamic Therapy Market Analysis and Forecast
13.1. Introduction
13.1.1. Key Findings
13.2. Market Value Forecast, by Product Type, 2017–2031
13.2.1. Photosensitizer Drugs
13.2.1.1. Porphyrin Derivative (PD)
13.2.1.1.1. Hematoporphyrin Derivative (HpD)
13.2.1.1.2. Benzoporphyrin Derivative (BPD)
13.2.1.1.3. Texaphyrins
13.2.1.1.4. Others
13.2.1.2. Aminolevulinic acid (ALA)
13.2.1.3. Chlorines
13.2.1.4. Others
13.2.2. Devices
13.2.2.1. Disposable Fiber Optic Light Delivery Devices (DFOLDD)
13.2.2.2. Diode Laser
13.3. Market Value Forecast, by Application, 2017–2031
13.3.1. Cancer
13.3.1.1. Basal Cell Carcinoma
13.3.1.2. Non-Small Cell Lung Cancer
13.3.1.3. Head & Neck Cancer
13.3.1.4. Others
13.3.2. Actinic Keratosis (AK)
13.3.3. Psoriasis
13.3.4. Acne
13.3.5. Others
13.4. Market Value Forecast, by End-user, 2017–2031
13.4.1. Hospitals
13.4.2. C&DC
13.4.3. CCC
13.4.4. Others
13.5. Market Value Forecast, by Country/Sub-region, 2017–2031
13.5.1. Brazil
13.5.2. Mexico
13.5.3. Rest of Latin America
13.6. Market Attractiveness Analysis
13.6.1. By Product Type
13.6.2. By Application
13.6.3. By End-user
13.6.4. By Country/Sub-region
14. Middle East & Africa Photodynamic Therapy Market Analysis and Forecast
14.1. Introduction
14.1.1. Key Findings
14.2. Market Value Forecast, by Product Type, 2017–2031
14.2.1. Photosensitizer Drugs
14.2.1.1. Porphyrin Derivative (PD)
14.2.1.1.1. Hematoporphyrin Derivative (HpD)
14.2.1.1.2. Benzoporphyrin Derivative (BPD)
14.2.1.1.3. Texaphyrins
14.2.1.1.4. Others
14.2.1.2. Aminolevulinic acid (ALA)
14.2.1.3. Chlorines
14.2.1.4. Others
14.2.2. Devices
14.2.2.1. Disposable Fiber Optic Light Delivery Devices (DFOLDD)
14.2.2.2. Diode Laser
14.3. Market Value Forecast, by Application, 2017–2031
14.3.1. Cancer
14.3.1.1. Basal Cell Carcinoma
14.3.1.2. Non-Small Cell Lung Cancer
14.3.1.3. Head & Neck Cancer
14.3.1.4. Others
14.3.2. Actinic Keratosis (AK)
14.3.3. Psoriasis
14.3.4. Acne
14.3.5. Others
14.4. Market Value Forecast, by End-user, 2017–2031
14.4.1. Hospitals
14.4.2. C&DC
14.4.3. CCC
14.4.4. Others
14.5. Market Value Forecast, by Country/Sub-region, 2017–2031
14.5.1. GCC Countries
14.5.2. South Africa
14.5.3. Rest of Middle East & Africa
14.6. Market Attractiveness Analysis
14.6.1. By Product Type
14.6.2. By Application
14.6.3. By End-user
14.6.4. By Country/Sub-region
15. Competition Landscape
15.1. Market Player - Competition Matrix (by tier and size of companies)
15.2. Market Share Analysis, by Company, 2021
15.3. Company Profiles
15.3.1. Galderma Laboratories, L.P.
15.3.1.1. Company Overview
15.3.1.2. Financial Overview
15.3.1.3. Product Portfolio
15.3.1.4. Business Strategies
15.3.1.5. Recent Developments
15.3.2. Biofrontera AG
15.3.2.1. Company Overview
15.3.2.2. Financial Overview
15.3.2.3. Product Portfolio
15.3.2.4. Business Strategies
15.3.2.5. 15.3.1.5. Recent Developments
15.3.3. Excel Lasers Limited
15.3.3.1. Company Overview
15.3.3.2. Financial Overview
15.3.3.3. Product Portfolio
15.3.3.4. Business Strategies
15.3.3.5. Recent Developments
15.3.4. LUMIBIRD group (Quantel Medical)
15.3.4.1. Company Overview
15.3.4.2. Financial Overview
15.3.4.3. Product Portfolio
15.3.4.4. Business Strategies
15.3.4.5. Recent Developments
15.3.5. Modulight Corporation
15.3.5.1. Company Overview
15.3.5.2. Financial Overview
15.3.5.3. Product Portfolio
15.3.5.4. Business Strategies
15.3.5.5. Recent Developments
15.3.6. Quest PharmaTech, Inc.
15.3.6.1. Company Overview
15.3.6.2. Financial Overview
15.3.6.3. Product Portfolio
15.3.6.4. Business Strategies
15.3.6.5. Recent Developments
15.3.7. Theralase Technologies, Inc.
15.3.7.1. Company Overview
15.3.7.2. Financial Overview
15.3.7.3. Product Portfolio
15.3.7.4. Business Strategies
15.3.7.5. Recent Developments
15.3.8. SUS Advancing Technology Co., Ltd.
15.3.8.1. Company Overview
15.3.8.2. Financial Overview
15.3.8.3. Product Portfolio
15.3.8.4. Business Strategies
15.3.8.5. Recent Developments
List of Tables
Table 01: Global Photodynamic Therapy Market Value (US$ Mn) Forecast, by Product Type, 2017–2031
Table 02: Global Photodynamic Therapy Market Value (US$ Mn) Forecast, by Photosensitizer Drugs, 2017–2031
Table 03: Global Photodynamic Therapy Market Value (US$ Mn) Forecast, by Porphyrin Derivative (PD), 2017–2031
Table 04: Global Photodynamic Therapy Market Value (US$ Mn) Forecast, by Devices, 2017–2031
Table 05: Global Photodynamic Therapy Market Value (US$ Mn) Forecast, by Application, 2017–2031
Table 06: Global Photodynamic Therapy Market Value (US$ Mn) Forecast, by Cancer, 2017–2031
Table 07: Global Photodynamic Therapy Market Value (US$ Mn) Forecast, by End-user, 2017–2031
Table 08: Global Photodynamic Therapy Market Value (US$ Mn) Forecast, by Region , 2017–2031
Table 09: North America Photodynamic Therapy Market Revenue (US$ Mn) Forecast, by Country, 2017–2031
Table 10: North America Photodynamic Therapy Market Value (US$ Mn) Forecast, by Product Type,2017–2031
Table 11: North America Photodynamic Therapy Market Value (US$ Mn) Forecast, by Photosensitizer Drugs, 2017–2031
Table 12: North America Photodynamic Therapy Market Value (US$ Mn) Forecast, by Porphyrin Derivative (PD), 2017–2031
Table 13: North America Photodynamic Therapy Market Value (US$ Mn) Forecast, by Devices,2017–2031
Table 14: North America Photodynamic Therapy Market Value (US$ Mn) Forecast, by Application, 2017–2031
Table 15: North America Photodynamic Therapy Market Value (US$ Mn) Forecast, by Cancer, 2017–2031
Table 16: North America Photodynamic Therapy Market Value (US$ Mn) Forecast, by End-user, 2017–2031
Table 17: Europe Photodynamic Therapy Market Revenue (US$ Mn) Forecast, by Country/Sub-region, 2017–2031
Table 18: Europe Photodynamic Therapy Market Value (US$ Mn) Forecast, by Product Type, 2017–2031
Table 19: Europe Photodynamic Therapy Market Value (US$ Mn) Forecast, by Photosensitizer Drug, 2017–2031
Table 20: Europe Photodynamic Therapy Market Value (US$ Mn) Forecast, by Porphyrin Derivative (PD), 2017–2031
Table 21: Europe Photodynamic Therapy Market Value (US$ Mn) Forecast, by Devices, 2017–2031
Table 22: Europe Photodynamic Therapy Market Value (US$ Mn) Forecast, by Application, 2017–2031
Table 23: Europe Photodynamic Therapy Market Value (US$ Mn) Forecast, by Cancer, 2017–2031
Table 24: Europe Photodynamic Therapy Market Value (US$ Mn) Forecast, by End-user, 2017–2031
Table 25: Asia Pacific Photodynamic Therapy Market Revenue (US$ Mn) Forecast, by Country/Sub-region, 2017–2031
Table 26: Asia Pacific Photodynamic Therapy Market Value (US$ Mn) Forecast, by Product Type, 2017–2031
Table 27: Asia Pacific Photodynamic Therapy Market Value (US$ Mn) Forecast, by Photosensitizer Drugs, 2017–2031
Table 28: Asia Pacific Photodynamic Therapy Market Value (US$ Mn) Forecast, by Porphyrin Derivative (PD), 2017–2031
Table 29: Asia Pacific Photodynamic Therapy Market Value (US$ Mn) Forecast, by Devices, 2017–2031
Table 30: Asia Pacific Photodynamic Therapy Market Value (US$ Mn) Forecast, by Application, 2017–2031
Table 31: Asia Pacific Photodynamic Therapy Market Value (US$ Mn) Forecast, by Cancer, 2017–2031
Table 32: Asia Pacific Photodynamic Therapy Market Value (US$ Mn) Forecast, by End-user, 2017–2031
Table 33: Latin America Photodynamic Therapy Market Revenue (US$ Mn) Forecast, by Country/Sub-region, 2017–2031
Table 34: Latin America Photodynamic Therapy Market Value (US$ Mn) Forecast, by Product Type, 2017–2031
Table 35: Latin America Photodynamic Therapy Market Value (US$ Mn) Forecast, by Photosensitizer Drugs, 2017–2031
Table 36: Latin America Photodynamic Therapy Market Value (US$ Mn) Forecast, by Porphyrin Derivative (PD), 2017–2031
Table 37: Latin America Photodynamic Therapy Market Value (US$ Mn) Forecast, by Devices, 2017–2031
Table 38: Latin America Photodynamic Therapy Market Value (US$ Mn) Forecast, by Application, 2017–2031
Table 39: Latin America Photodynamic Therapy Market Value (US$ Mn) Forecast, by Cancer, 2017–2031
Table 40: Latin America Photodynamic Therapy Market Value (US$ Mn) Forecast, by End-user, 2017–2031
Table 41: Middle East & Africa Photodynamic Therapy Market Revenue (US$ Mn) Forecast, by Country/Sub-region, 2017–2031
Table 42: Middle East & Africa Photodynamic Therapy Market Value (US$ Mn) Forecast, by Product Type, 2017–2031
Table 43: Middle East & Africa Photodynamic Therapy Market Value (US$ Mn) Forecast, by Photosensitizer Drugs, 2017–2031
Table 44: Middle East & Africa Photodynamic Therapy Market Value (US$ Mn) Forecast, by Porphyrin Derivative (PD), 2017–2031
Table 45: Middle East & Africa Photodynamic Therapy Market Value (US$ Mn) Forecast, by Devices, 2017–2031
Table 46: Middle East & Africa Photodynamic Therapy Market Value (US$ Mn) Forecast, by Application, 2017–2031
Table 47: Middle East & Africa Photodynamic Therapy Market Value (US$ Mn) Forecast, by Cancer, 2017–2031
Table 48: Middle East & Africa Photodynamic Therapy Market Value (US$ Mn) Forecast, by End-user, 2017–2031
List of Figures
Figure 01: Global Photodynamic Therapy Market Value (US$ Mn) Forecast, 2017–2031
Figure 02: Global Photodynamic Therapy Market Value Share (%), by Product Type, 2021
Figure 03: Global Photodynamic Therapy Market Value Share (%), by Drugs, 2021
Figure 04: Global Photodynamic Therapy Market Value Share (%), by Application, 2021
Figure 05: Global Photodynamic Therapy Market Value Share (%), by Region, 2021
Figure 06: Global Photodynamic Therapy Market Value Share (%), by Product Type, 2017 and 2031
Figure 07: Global Photodynamic Therapy Market Value Share (%), by Photosensitizer Drugs, 2017 and 2031
Figure 08: Global Photodynamic Therapy Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Photosensitizer Drugs, 2017–2031
Figure 09: Global Photodynamic Therapy Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Devices, 2017–2031
Figure 10: Global Photodynamic Therapy Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Porphyrin Derivative (PD), 2017–2031
Figure 11: Global Photodynamic Therapy Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Aminolevulinic Acid (ALA), 2017–2031
Figure 12: Global Photodynamic Therapy Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Chlorines, 2017–2031
Figure 13: Global Photodynamic Therapy Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Others, 2017–2031
Figure 14: Global Photodynamic Therapy Market Revenue (US$ Mn) and Y-o-Y Growth (%), by DFOLDD, 2017–2031
Figure 15: Global Photodynamic Therapy Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Diode Laser, 2017–2031
Figure 16: Global Photodynamic Therapy Market Attractiveness Analysis, by Product Type, 2021–2031
Figure 17: Global Photodynamic Therapy Market Attractiveness Analysis, by Photosensitizer Drugs, 2021–2031
Figure 18: Global Photodynamic Therapy Market Attractiveness Analysis, by Devices, 2021–2031
Figure 19: Global Photodynamic Therapy Market Value Share (%), by Application, 2017 and 2031
Figure 20: Global Photodynamic Therapy Market Attractiveness Analysis, by Application, 2021–2031
Figure 21: Global Photodynamic Therapy Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Cancer, 2017–2031
Figure 22: Global Photodynamic Therapy Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Actinic Keratosis (AK), 2017–2031
Figure 23: Global Photodynamic Therapy Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Psoriasis, 2017–2031
Figure 24: Global Photodynamic Therapy Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Acne, 2017–2031
Figure 25: Global Photodynamic Therapy Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Others, 2017–2031
Figure 26: Global Photodynamic Therapy Market Value Share (%), by End-user, 2017 and 2031
Figure 27: Global Photodynamic Therapy Market Attractiveness Analysis, by End-user, 2022–2031
Figure 28: Global Photodynamic Therapy Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Hospitals, 2017–2031
Figure 29: Global Photodynamic Therapy Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Cosmetics & Dermatology Clinics, 2017–2031
Figure 30: Global Photodynamic Therapy Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Cancer Treatment Centers, 2017–2031
Figure 31: Global Photodynamic Therapy Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Others, 2017–2031
Figure 32: Global Photodynamic Therapy Market Value Share Analysis, by Region, 2017 and 2031
Figure 33: Global Photodynamic Therapy Market Attractiveness Analysis, by Region, 2021-2031
Figure 34: North America Photodynamic Therapy Market Revenue (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2017–2031
Figure 35: North America Photodynamic Therapy Market Value Share (%), by Country, 2017 and 2031
Figure 36: North America Photodynamic Therapy Market Attractiveness Analysis, by Country, 2022–2031
Figure 37: North America Photodynamic Therapy Market Value Share, by Product Type, 2017and 2031
Figure 38: North America Photodynamic Therapy Market Attractiveness Analysis, by Product Type, 2022–2031
Figure 39: North America Photodynamic Therapy Market Value Share, by Application, 2017 and 2031
Figure 40: North America Photodynamic Therapy Market Attractiveness Analysis, by Application, 2022–2031
Figure 41: North America Photodynamic Therapy Market Value Share, by End-user, 2017 and 2031
Figure 42: North America Photodynamic Therapy Market Attractiveness Analysis, by End-user, 2022–2031
Figure 43: Europe Photodynamic Therapy Market Revenue (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2017-2031
Figure 44: Europe Photodynamic Therapy Market Value Share (%), by Country/Sub-region, 2017and 2031
Figure 45: Europe Photodynamic Therapy Market Attractiveness Analysis, by Country/Sub-region, 2022-2031
Figure 46: Europe Photodynamic Therapy Market Value Share, by Product Type, 2017 and 2031
Figure 47: Europe Photodynamic Therapy Market Attractiveness Analysis, by Product Type, 2022–2031
Figure 48: Europe Photodynamic Therapy Market Value Share, by Application, 2017 and 2031
Figure 49: Europe Photodynamic Therapy Market Attractiveness Analysis, by Application, 2022–2031
Figure 50: Europe Photodynamic Therapy Market Value Share, by End-user, 2017 and 2031
Figure 51: Europe Photodynamic Therapy Market Attractiveness Analysis, by End-user, 2022–2031
Figure 52: Asia Pacific Photodynamic Therapy Market Revenue (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2017–2031
Figure 53: Asia Pacific Photodynamic Therapy Market Value Share (%), by Country/Sub-region, 2017 and 2031
Figure 54: Asia Pacific Photodynamic Therapy Market Attractiveness Analysis, by Country/Sub-region, 2022–2031
Figure 55: Asia Pacific Photodynamic Therapy Market Value Share, by Product Type, 2017 and 2031
Figure 56: Asia Pacific Photodynamic Therapy Market Attractiveness Analysis, by Product Type, 2022–2031
Figure 57: Asia Pacific Photodynamic Therapy Market Value Share, by Application, 2017 and 2031
Figure 58: Asia Pacific Photodynamic Therapy Market Attractiveness Analysis, by Application, 2022–2031
Figure 59: Asia Pacific Photodynamic Therapy Market Value Share, by End-user, 2017 and 2031
Figure 60: Asia Pacific Photodynamic Therapy Market Attractiveness Analysis, by End-user, 2022–2031
Figure 61: Latin America Photodynamic Therapy Market Revenue (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2017–2031
Figure 62: Latin America Photodynamic Therapy Market Value Share (%), by Country/Sub-region, 2017 and 2031
Figure 63: Latin America Photodynamic Therapy Market Attractiveness Analysis, by Country/Sub-region, 2022–2031
Figure 64: Latin America Photodynamic Therapy Market Value Share, by Product Type, 2017 and 2031
Figure 65: Latin America Photodynamic Therapy Market Attractiveness Analysis, by Product Type, 2017–2031
Figure 66: Latin America Photodynamic Therapy Market Value Share, by Application, 2017 and 2031
Figure 67: Latin America Photodynamic Therapy Market Attractiveness Analysis, by Application, 2017–2031
Figure 68: Latin America Photodynamic Therapy Market Value Share, by End-user, 2017 and 2031
Figure 69: Latin America Photodynamic Therapy Market Attractiveness Analysis, by End-user, 2022–2031
Figure 70: Middle East & Africa Photodynamic Therapy Market Revenue (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2017-2031
Figure 71: Middle East & Africa Photodynamic Therapy Market Value Share (%), by Country/Sub-region, 2017 and 2031
Figure 72: Middle East & Africa Photodynamic Therapy Market Attractiveness Analysis, by Country/Sub-region, 2022–2031
Figure 73: Middle East & Africa Photodynamic Therapy Market Value Share, by Product Type, 2017 and 2031
Figure 74: Middle East & Africa Photodynamic Therapy Market Attractiveness Analysis, by Product Type, 2022–2031
Figure 75: Middle East & Africa Photodynamic Therapy Market Value Share, by Application, 2017 and 2031
Figure 76: Middle East & Africa Photodynamic Therapy Market Attractiveness Analysis, by Application, 2022–2031
Figure 77: Middle East & Africa Photodynamic Therapy Market Value Share, by End-user, 2017 and 2031
Figure 78: Middle East & Africa Photodynamic Therapy Market Attractiveness Analysis, by End-user, 2022–2031
Complete the form below and we'll get back to you shortly.
Copyright © Transparency Market Research, Inc. All Rights reserved
Trust Online
